Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
24.22
-0.20 (-0.82%)
Nov 21, 2024, 4:00 PM EST - Market closed
Denali Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$38.90
Upside
+60.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +271.59% | Nov 7, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $40 → $45 | Strong Buy | Maintains | $40 → $45 | +85.80% | Nov 1, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $29 → $28 | Buy | Maintains | $29 → $28 | +15.61% | Oct 11, 2024 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $35 | Buy | Reiterates | $35 | +44.51% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +271.59% | Sep 4, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $25 → $29 | Strong Buy | Maintains | $25 → $29 | +19.74% | Sep 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +271.59% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $95 → $90 | Strong Buy | Maintains | $95 → $90 | +271.59% | Aug 5, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $26 → $32 | Strong Buy | Maintains | $26 → $32 | +32.12% | Aug 2, 2024 |
| Wedbush | Wedbush | Buy Maintains $30 → $26 | Buy | Maintains | $30 → $26 | +7.35% | Aug 2, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $28 → $29 | Buy | Maintains | $28 → $29 | +19.74% | Jul 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +292.24% | May 8, 2024 |
| Wedbush | Wedbush | Buy Maintains $31 → $30 | Buy | Maintains | $31 → $30 | +23.86% | May 8, 2024 |
| Stifel | Stifel | Hold Maintains $26 → $22 | Hold | Maintains | $26 → $22 | -9.17% | May 8, 2024 |
| UBS | UBS | Strong Buy Maintains $70 → $32 | Strong Buy | Maintains | $70 → $32 | +32.12% | Apr 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.